ERYTECH Pharma S.A.
ERYP · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $10 | $17 | $33 | $49 |
| - Cash | $39 | $0 | $53 | $0 |
| + Debt | $14 | $0 | $4 | $0 |
| Enterprise Value | -$16 | $17 | -$16 | $49 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $4 | -$2 | $17 | -$11 |
| % Margin | – | – | – | – |
| Net Income | $6 | -$5 | $11 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.19 | -0.17 | 0.35 | -0.38 |
| % Growth | 211.8% | -148.6% | 192.1% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |